Unexpected mortality from the use of E. coli L-asparaginase during remission induction therapy for childhood acute lymphoblastic leukemia: A report from the Taiwan Pediatric Oncology Group

KAI-HSIN LIN2018-09-102018-09-101999http://www.scopus.com/inward/record.url?eid=2-s2.0-0033000574&partnerID=MN8TOARShttp://scholars.lib.ntu.edu.tw/handle/123456789/353812Unexpected mortality from the use of E. coli L-asparaginase during remission induction therapy for childhood acute lymphoblastic leukemia: A report from the Taiwan Pediatric Oncology Groupjournal article10.1038/sj.leu.2401260